Weight-loss drugs were said to be a game changer. Turns out the benefit might be thinner than thought

Common GLP-1 weight loss drugs - including Wegovy and Ozempic - may not work for everyone in a “real-world” setting, Cleveland Clinic researchers said Tuesday.

The reason is that patients may take lower dosages or discontinue their treatment, negatively impacting the ability to control blood sugar levels in those who are pre-diabetic.